Dynavax Technologies Corporation (DVAX) Reviewed By Analysts

United States of America based company, Dynavax Technologies Corporation (DVAX)'s latest closing price distance was at -33.02% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 67.54% and 69.90% compared with the 20 Day Moving Average.

Target Corp. shares were suffering their biggest-ever price drop in active trade Tuesday, as the discount retail giant struggles to cope with the "rapidly changing" behavior of consumers.

The consensus recommendation, according to Zacks Investment research, is 2.33. Here, 1 indicates a Strong Buy and 5 indicates a Strong Sell. Analyst's mean target price for HTZ is $29.14 while analysts mean recommendation is 2.90.

Dynavax Technologies Corporation on 11/07/2016 reported its EPS as $-0.9 with the analysts projecting the EPS of the stock as $-0.75.

For the ongoing Fiscal Quarter, 2 analysts have an average earnings forecast of $-0.55 per share. Hence, the surprise factor was -10.3 percent. Dynavax Technologies Corporation P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0. On annual basis of EPS, FY 2017 Estimate Trends at current were for $-1.95 and for the one month was for $-3.25 as compared to three months ago was for $-3.25.

Investors expected a price target of -0.34 for this quarter.

For the quarter ending 08/05/2016, The Analyst projected that the company could deliver EPS of -0.68 while the company provided its Actual EPS of -0.75 showing a difference of -0.07 Percent between the Estimated and Actual EPS. This estimate is provided by 4 analysts.

To view the price target ranked by analysts, DVAX attains high-level price target of 45 while lower level target was 4, it can be use an indication to know how much worth stock has stored in it. This Company belongs to Medical sector. The total volume of 1.4 Million shares held in the session was surprisingly higher than its average volume of 1112.76 shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock touched its high share price of $23.62 on April 19, 2016 and the stock also touched its Lowest price in the last 52-weeks of trading on Nov 14, 2016 as $3.2. Sell-side analyst recommendations point to a short term price target of $22 on the company shares. They now have a Dollars 30 price target on the stock. In order to determine directional movement, the 50-day and 200-day moving averages for Dynavax Technologies Corporation (NASDAQ:DVAX) are $4.17 and $7.95. The company rocked its 52-Week High of $23.62 on April 19, 2016 and touched its 52-Week Low of $3.2 on Nov 14, 2016.

Indicating how profitable this stock is relative to its assets, the ROA value is observed at -65.90%. A ROI of -57.10% for the company evaluates and compares the efficiency of the various numbers of investments relative to the cost of investments. Taking a look into the performance of DVAX stock, investor will come to know that the weekly performance for this stock is valued at 72.50%, resulting in a performance for the month at 79.22%.

Latest News